Abbott raises full-year 2026 adjusted EPS guidance to $5.45–$5.60
Abbott raised its full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to the previous range of $5.38 to $5.58, after reporting…
$5.45$5.60
Company
SEC filing news and material events for ABBOTT LABORATORIES, briefed from primary-source filings.
1 story
Abbott raised its full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to the previous range of $5.38 to $5.58, after reporting…